Growth Metrics

Oscar Health (OSCR) Return on Sales (2020 - 2025)

Historic Return on Sales for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to 0.13%.

  • Oscar Health's Return on Sales fell 600.0% to 0.13% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.04%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.04% for FY2025, which is 400.0% down from last year.
  • As of Q4 2025, Oscar Health's Return on Sales stood at 0.13%, which was down 600.0% from 0.05% recorded in Q3 2025.
  • Oscar Health's Return on Sales' 5-year high stood at 0.09% during Q1 2025, with a 5-year trough of 0.48% in Q3 2021.
  • For the 5-year period, Oscar Health's Return on Sales averaged around 0.11%, with its median value being 0.08% (2022).
  • Its Return on Sales has fluctuated over the past 5 years, first skyrocketed by 8600bps in 2021, then tumbled by -1100bps in 2025.
  • Quarter analysis of 5 years shows Oscar Health's Return on Sales stood at 0.4% in 2021, then surged by 43bps to 0.23% in 2022, then skyrocketed by 54bps to 0.1% in 2023, then skyrocketed by 39bps to 0.06% in 2024, then tumbled by -96bps to 0.13% in 2025.
  • Its Return on Sales stands at 0.13% for Q4 2025, versus 0.05% for Q3 2025 and 0.08% for Q2 2025.